Gene therapy for articular cartilage repair

Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine

Volumn 221, Issue 5, 2007, Pages 451-459

  Trippell, S ^a   Cucchiarini, M ^b   Madry, H ^b   Shi, S ^a   Wang, C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Animal models; Arthritis; Articular cartilage; Gene therapy; Vectors

Indexed keywords

FIBROBLASTS; GENE ENCODING; JOINTS (ANATOMY); PATIENT REHABILITATION;

ARTICULAR CARTILAGE; CELL-REGULATORY MOLECULES; GENE THERAPY;

CARTILAGE;

SIGNAL PEPTIDE;

ANIMAL; ARTICULAR CARTILAGE; CARTILAGE FRACTURE; GENE THERAPY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INJURY; METHODOLOGY; REGENERATION; REVIEW;

ANIMALS; CARTILAGE, ARTICULAR; FRACTURES, CARTILAGE; GENE THERAPY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; REGENERATION;

EID: 34548134032     PISSN: 09544119     EISSN: None     Source Type: Journal    
DOI: 10.1243/09544119JEIM237     Document Type: Article

References (72)

1. Praemer, A., Furner, S., and Rice, D. P. Musculoskeletal conditions in the United States, 1999 (American Academy of Orthopaedic: Surgeons, Rosemont, Illinois).
2. Mankin, H. J. and Buckwalter, J. A. Restoration of the osteoarthrotic joint. J. Bone Jt Surg. Am., 1996, 78, 1-2.
3. Gudas, R., Kalesinskas, R. J., Kimtys, V., Stankevičlus, E., Toliušis, V., Bernotavičius, G., and Smallys, A. A prospective randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint in young athletes. Arthroscopy: J. Arthroscopic Related Surg., 2005, 21(9), 1066-1075.
4. Knutsen, G., Engebretsen, L, Ludvigsen, T. C., Drogset, J. O., Grentvedt, T., Solheim, E., Strand, T., Roberts, S., Isaksen, V., and Johansen, O. Autologous chondrocyte implantation compared with microfracture in the knee. J. Bone Jt Surg. Am., 2004, 86(3), 455-464.
5. Bentley, G., Blant, L. C., Carrington, R. W., Akmal, M., Goldberg, A., Williams, A. M., Skinner, J. A., and Pringle, J. A prospective randomized comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J. Bone Jt Surg. Br., 2003, 85, 223-230.
6. Horag, U., Pelinkovic, D., Herr, G., Aigner, T., and Schnettler, R. Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint. J. Bone Jt Surg. Am., 2003, 85(2), 185-192.
7. Trippel, S. B. Growth factor actions on articular cartilage. J. Rheumatology, 1995, 22 (Suppl. 43), 129-132.
8. Trippel, S. B., Coutts, R. D., Einhoin, T. A., Mundy, G. R., and Rosenfeld, R. Instructional course lectures: growth factors as therapeutic agents. J. Bone Jt Surg. Am., 1996, 78, 1272-1286.
9. Garcia, A. M., Lark, M. W., Trippel, S. B., and Grodzinsky, A. J. Transport of tissue inhibitor of metalloproteinase-1 through cartilage: contributions of fluid flow and electrical migration. J. Orthop. Res., 1998, 16, 734-742.
10. Garcia, A. M., Szasz, N., Trippel, S. B., Morales, T. I., Grodzinsky, A. J., and Frank, E. H. Transport and binding of IGF-I through articular cartilage. Arch. Biochemistry Biophysics, 2003, 415, 69-79.
11. McQuillan, D. J., Handley, C. J., Campbell, M. A., Bolis S., Milway, V. E., and Herington, A. C. Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor I in cultured bovine articular cartilage. Biochem. J., 1986, 240, 423-430.
12. Sandell, L. J. and Dudek, E. J. Insulin-like growth factor 1 stimulates type 11 collagen gene expression in cultured chondrocytes. Orthop. Trans., 1988, 12, 377-378.
13. Sah, R. L., Chen, A. C., Grodzinsky, A. J., and Trippel, S. B. Differential effects of b,FGF and IGF-1 on matrix metabolism in calf and adult bovine cartilage explants. Arch. Biochemistry Biophysics, 1994, 308(1), 137-147.
14. Sailor, L. Z., Hewick, R. M., and Mords, E. A. Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture. J. Orthop. Res., 1996, 14(6), 937-945.
15. Sellers, R. S., Zhang, R., Glasson, S. S., Kim, H. D., Peluso, D., D'Augusta, D. A., Beckwith, K., and Morris, E. A. Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). J. Bone Jt Surg. Am., 2000, 82(2), 151-160.
16. Brower-Toland, R. D., Saxer, R. A., Goodrich, L. R., Mi, Z., Robbins, P. D., Evans, C. H., and Nixon, A. J. Direct adenovirus-mediated insulin-like growth factor I gene transfer enhances transplant chondrocyte function. Hum. Gene Therapy, 2001, 12(2), 117-129.
17. Nixon, A. J., Brower-Toland, B. D., Bent, S. J., Saxer, R. A., Wilke, M. J., Robbins, P D., and Evang, C. H. Insulinlike growth facior-I gene therapy applications for cartilage repair. Clin. Orthop. Related Res., 2000, 379 (Suppl.), S201-S213.
18. Smith, P., Shuler, F. D., Georgescu, H. I., Ghivizzani, S. C., Johnstone, B., Niyibizi, C., Robbins, P. D., and Evans, C. H. Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis Rheum., 2000, 43(5), 1156-1164.
19. Shuler, F. D., Georgescu, H. I., Niyibizi, C., Studer, R. K., Mi, Z., Johnstone, B., Robbins, R. D., and Evans, C. H. Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J. Orthop. Res., 2000, 18(4), 585-592.
20. Benya, P. D., Padilla, S. R., and Nimni, M. E. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell, 1978, 15(4), 1313-1321.
21. von der Mark, K., Gauss, V., von der Mark, H., and Mueller, P. Relationship between cell shape and type of collagen synthesis as chondrocytes lose their cartilage phenotype in culture. Nature, 1977, 267, 531-532.
22. Tew, S. R., Li, Y., Pothacharoen, P., Tweats, L. M., Hawkins, R. E., and Hardingham, T. E. Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage, 2005, 13(1), 80-89.
23. Doherty, P. J., Zhang, H., Tremblay, L., Manolopoulos, V., and Marshall, K. W. Resurfacing of articular cartilage explants with genetically-modified human chondrocytes in vitro. Osteoarthritis Cartilage, 1998, 6(3), 153-159.
24. Hidaka, C., Quitoriano, M., Warren, R. F., and Crystal, R. G. Enhanced matrix synthesis and in vitro formation of cartilage-like tissue by genetically modified chondrocytes expressing BMP-7. J. Orthop. Res., 2001, 19(5), 751-758.
25. Madry, H., Emkey, G., Zurakowski, D., and Trippel, S. B. Overexpression of human fibroblast growth factor 2 stimulates cell proliferation in an ex vivo model of articular chondrocyte transplantation. J. Gene Medicine, 2004, 6(2), 238-245.
26. Madry, H., Zurakowski, D., and Trippel, S. B. Overexpression of human insulin-like growth factor-I promotes new tissue formation in an ex vivo model of articular chondrocyte transplantation. Gene Therapy, 2004, 8, 1443-1449.
27. Madry, H., Padera, B., Seidel, J., Freed, L., Langer, R., Trippel, S. B., and Vunjak-Novakovic, G. Gene transfer of a human insulin-like growth factor 1 cDNA enhances tissue engineering of cartilage. Hum. Gene Therapy, 2002, 13, 1621-1630.
28. Diduch, D. R., Jordan, L. C., Mierisch, C. M., and Balian, G. Marrow stromal cells embedded in alginate for repair of osteochondral defects. Arthroscopy, 2000, 16(6), 571-577.
29. Kaul, G., Cucchiarini, M., Arntzen, D., Zurakowski, D., Menger, M. D., Kohn, D., Trippel, S. B., and Madry, H. Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo. J. Gene Medicine, 2006, 8(1), 100-111.
30. Madry, H., Cucchiarini, M., Stein, U., Remberger, K., Menger, M. D., Kohn, D., and Trippel, S. B. Sustained transgene expression in-cartilage defects in vivo after transplantation of articular chondrocytes modified by lipid-mediated gene transfer in a gel suspension delivery system. J. Gene Medicine, 2003, 5(6), 502-509.
31. Madry, H., Kaul, G., Cucchiarini, M., Stein, U., Zurakowski, D., Remberger, K., Menger, M. D., Kohn, D., and Trippel, S. B. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IdF-I). Gene Therapy, 2005, 12(14), 1171-1179.
32. Baragi, V. M., Renkiewicz, R. R., Jordan, H., Bonadio, J., Hartman, J. W., and Roessler, B. J. Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. J. Clin. Invest., 1995, 96(5), 2454-2460.
33. Li, Y., Tew, S. R., Russell, A. M., Gonzalez, K. R., Hardingham, T. E., and Hawkins, R. E. Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. Tissue Engng, 2004, 10(3-4), 575-584.
34. MacDonald, M. H., Stover, S. M., Willits, N. H., and Benton, H. P. Regulation of matrix metabolism in equine cartilage explant cultures by interleukin-1. Am. J. Vet. Res., 1992, 53, 2278-2285.
35. Muller-Ladner, U., Roberts, C. R., Franklin, B. N., Gay, R. E., Robbins P. D., Evans, C. H., and Gay, S. Human IL-Ira gene transfer into human synovial fibroblasts is chondroprotective. J. Immunology, 1997, 158, 3492-3498.
36. Pan, R. Y., Chen, S. L., Xiao, X., Liu, D. W., Peng, H. J., and Tsao, Y. P. Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist. Arthritis Rheum., 2000, 43(2), 289-297.
37. Bandara, G., Mueller, G. M., Galea-Lauri, J., Tindal, M. H., Georgescu, H. I., Suchanek, M. K., Hung, G. L., Glorioso, J. C., Robbins, P. D., and Evans, C. H. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene tansfer. Proc. Natn. Acad. Sci. USA, 1993, 90, 10764-10768.
38. Zhang, X., Mae, Z., and Yu, C. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10. J. Orthop. Res., 2004, 22, 742-750.
39. Fernandes, J., Tardif, G., Martel-Pelletier, J., Lascau-Coman, V., Dupuis, M., Moldovan, F., Sheppard, M., Krishnan, B. R., and Pelletier, J. P. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints. Am. J. Pathology, 1999, 154(4), 1159-1169.
40. Pelletier, J. P., Caron, J. P., Evans, C. H., Robbins, P. D., Georgescu, H. I., Jovanovic, D., Fernandes, J. C., and Martel-Pelletier, J. In vivo suppression of early experimental osteoarthritis by IL-Ra using gene therapy. Arthritis Rheum., 1997, 40, 1012-1019.
41. Frisbie, D. D., Ghivizzani, S. C., Robbins, P. D., Evans, C. H., and McIlwraith, C. W. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Therapy, 2002, 9, 12-20.
42. Evans, C. H., Robbins, P. D., Ghivizzani, S. C., Wasko, M. C., Tomaino, M. M., Kang, R., Muzzonigro, T. A., Vogt, M., Elder, E. M., Whiteside, T. L., Watkins, S. C., and Herndon, J. H. Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc. Natn. Acad. Sci. USA, 2005, 102(24), 8698-8703.
43. Gelse, K., Jiang, Q. J., Aigner, T., Ritter, T., Wagner, K., Pöschl, E., von der Mark, K., and Schneider, H. Fibroblast-mediated delivery of growth factor complementary DNA into mouse joints induces chondrogenesis but avoids the disadvantages of direct viral gene transfer. Arthritis Rheum., 2001, 44(8), 1943-1953.
44. Mi, Z., Ghivizzani, S. C., Lechman, E. R., Jaffurs, D., Glorioso, J. C., Evans, C. H., and Robbins, P. D. Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. Arthritis Rheum., 2000, 43(11), 2563-2570.
45. Cucchiarini, M., Madry, H., Ma, C., Thurn, T., Zurakowski, D., Menger, M. D., Kohn, D., Trippel, S. B., and Terwilliger, E. F. Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. Molecular Therapy, 2005, 12, 229-238.
46. Hiraide, A., Yokoo, N., Xin, K., Okuda, K., Mizukami, H., Ozewa, K., and Saito, T. Repair of articular cartilage defect by intraarticular administration of basic fibroblast growth factor gene, using adeno-associated virus vector. Hum. Gene Therapy, 2005, 16, 1413-1421.
47. Yokoo, N., Saito, T., Uesugi, M., Kobayashi, N., Xin, K. Q., Okuda, K., Mizukaml, H., Ozawa, K., and Koshino, T. Repair of articular cartilage defect by autologous transplantation of basic fibroblast growth factor gene-transduced chondrocytes with adeno-associated virus vector. Arthritis Rheum., 2005, 52(1), 164-170.
48. Ikeda, T., Kubo, T., Arai, Y., Nakanishi, T., Kobayashi, K., Takahashi, K., Imanishi, J., Takigawa, M., and Hirasawa, Y. Adenovirus mediated gene delivery to the joints of guinea pigs. J. Rheumatology, 1998, 25, 1666-1673.
49. Lee, K. H., Song, S. U., Hwang, T. S., Yi, Y., Oh, I. S., Lee, J. Y., Choi, K. B., Choi, M. S., and Kim, S. J. Regeneration of hyaline cartilage by cell-mediated gene therapy using transforming growth factor beta 1-producing fibroblasts. Hum. Gene Therapy, 2001, 12, 1805-1813.
50. Scharstuhl, A., Vitters, E. L., van der Kraan, P. M., and van den Berg, W. B. Reduction of ostephyte formation and synovial thickening by adenoviral overexpression of transforming growth factor β/ bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum., 2003, 48(12), 3442-3451.
51. Kuroda, R., Usas, A., Kabo, S., Corsi, K., Peng, H., Rose, T., Cummins, J., Fu, F. H., and Huard, J. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum., 2006, 54(2), 433-442.
52. Grande, D. A., Mason, J., Light, E., and Dines, D. Stem cells as platforms for delivery of genes to enhance cartilage repair. J. Bone Jt Surg. Am., 2003, 85 (Suppl. 2), 111-116.
53. Hidaka, C., Goodrich, L. R., Chen, C., Warren, R. F., Crystal, R. G., and Nixon, A. J. Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7. J. Orthop. Res., 2003, 21, 573-583.
54. Roessler, B. J., Allen, E. D., Wilson, J. M., Hartman, J. W., and Davidson, B. L. Adenoviral-mediated gene transfer to rabbit synovium in vivo. J. Clin. Invest., 1993, 92(2), 1085-1092.
55. Watanabe, S., Imagawa, T., Boivin, G. P., Gao, G., Wilson, J. M., and Hirsch, R. Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium. Molecular Therapy 2000, 2(2), 147-152.
56. Zhang, H. G., Xie, J., Yang, P., Wang, Y., Xu, L., Liu, D., Hsu, H., Zhou, T., Edwards, C. A. III, and Mountz, J. D. Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis. Hum. Gene Therapy, 2000, 11, 2431-2442.
57. Madry, H., Cucchiarini, M., Terwilliger, E. F., and Trippel, S. B. Recombinant adeno-associated vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. Hum. Gene Therapy, 2003, 14, 393-402.
58. Tsuru, M., Nagata, K., Ueno, T., Jimi, A., Noda, S., Iida, S., and Sata, M. Confocal laser microscopy of chondrocytes that received gene transfer using in vitro electroporation. Kurume Med. J., 2002, 49(1-2), 1-5.
59. Madry, H. and Trippel, S. B. Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Therapy, 2000, 7, 286-291.
60. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J. I., de Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Souller, J., Leiva, L. E., Wissler, M., Prinz, C., Rabbitts, T. H., Le Deist, F.., Fischer, A., and Cavazzana-Calvo, M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-XI. Science, 2003, 302, 415-419.
61. Kang, R., Marui, T., Ghivizzani, S. C., Nita, I. M., Georgescu, H. I., Suh, J. K., Robbins, P. D., Evans, C. H., and Ferguson, A. B. Jr Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. Osteoarthritis Cartilage, 1997, 5, 139-143.
62. Ikeda, T., Kubo, T., Nakanishi, T., Arai, Y., Kobayashi, K., Mazda, O., Ohashi, S., Takahashi, K., Imanishi, J., Takigawa, M., and Hirasawa, Y. Ex vivo gene delivery using an adenovirus vector in treatment for cartilage defects. J. Rheumatology, 2000, 27, 990-996.
63. Dettweiler, U. and Simon, P. Points to consider for ethics committees in human gene therapy trials. Bioethics, 2001, 15(5-6), 491-500.
64. Nixon, A. J., Haupt, J. L., Frishle, D. D., Morisset, S. S., McIlwraith, C. W., Robbins, P. D., Evans, C. H., and Ghivizzani, S. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy. Gene Therapy, 2005, 12, 177-186.
65. Madry, H., Cucchiarini, M., Kaul, G., Kohn, D., Terwilliger, E. F., and Trippel, S. B. Menisci are efficiently transduced by recombinant adeno-associated virus vectors in vitro and in vivo. Am. J. Sports Medicine, 2004, 32 1860-1865.
66. Goater, J., Muller, R., Kollias, G., Firestein, G. S., Sanz, I., O'Keefe, R. J., and Schwarz, E. M. Empirical advantages of adeno associated viral vectors for in vivo gene therapy for arthritis. J. Rheumatology, 2000, 27(4), 983-989.
67. Ulrich-Vinther, M., Duch, M. R., Soballe, K., O'Keefe, R. J., Schwarz, E. M., and Pedersen, F. S. In vivo gene delivery to articular chondrocytes mediated by an adeno-associated virus vector. J. Orthop. Res., 2004, 22(4), 726-734.
68. Duan, D., Yue, Y., Yan, Z., and Engelhardt, J. F. A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nature Medicine, 2000, 6(5), 595-598.
69. Yan, Z., Zhang, Y., Duan, D., and Engelhardt, J. F. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc. Natn. Acad. Sci. USA, 2000, 97(12), 6716-6721.
70. Kafri, T. Lentivirus vector: difficulties and hopes before clinical trials. Curr. Opin. Molecular Therapy, 2001, 4(3), 316-326.
71. Gouze, E., Pawliuk, R., Pilapil, C., Gouze, J. N., Fleet, C., Palmer, G. D., Evans, C. H., Leboulch, P., and Ghivizzani S. C. In vivo gene delivery to synovium by lentiviral vectors. Molecular Therapy, 2002, 5(4), 397-404.
72. Lu, F. Z., Kitazawa, Y., Hara, Y., Jiang, J. Y., and Li, X. K. Long-term gene expression using the lentiviral vector in rat chondrocytes. Clin. Orthop. Related Res., 2005, 439, 243-252.